Salivary and serum levels of soluble E-cadherin in patients with gastrointestinal cancers: A comparative study.
Journal:
Journal of cancer research and therapeutics
PMID:
38376307
Abstract
AIM: According to the literature, high levels of salivary soluble E-cadherin may be lined to advanced stage and poor prognosis in cancers. This research aimed at comparing salivary and serum levels of soluble E-cadherin in cases with esophageal, gastric, and colorectal cancers.